Can economies handle a
second wave of Covid-19?

  • Tweet
  • Share on LinkedIn
  • Share via email
  • Print
  • Download

August 24, 2020
 

Countries all over the world are easing out of lockdown in the search for a ‘new’ normal. But could we be on the brink of another Covid-19 economic hit? Newton chief investment officer Curt Custard gives his take on how investors might prepare for a second round of the virus.

The start of a new decade is oftentimes looked at as an exciting milestone, but it is evident 2020 has not been the year many thought it would be. Covid-19 shook up the globe and negatively impacted a multitude of industries and sectors. Markets plummeted, and despite momentum returning, the question on many investors’ lips is this: could another Covid-19 hit be on the horizon?

Scientists have expressed their concern over a second wave reaching the Northern Hemisphere in the fall of this year,1 when ‘flu season’ hits.

No one can predict the future, but Custard, chief investment officer at Newton believes smart investors need to be prepared for any outcome. He contends the pandemic has accelerated a number of investment themes that involve demands on healthcare and technology while challenging others such as (what was once) China’s growing influence. “It’s created a set of ‘winners’ and ‘losers’ that are likely to persist beyond the end of the crisis,” he says.

“I would expect more volatility as the market digests job and earnings data as the first round of stimulus begins to wear off. I think we’ll continue to see swings in the types of companies investors expect to do well.”

In regards to asset classes, if a second wave were to happen later this year, Custard believes equities would take the hardest hit. “Equities will likely be impacted most directly as they have rallied ‘through’ this pandemic and arguably have a lot of good news baked into the price,” he says.

“High Yield credit would likely be the next asset class to be affected as there remain questions about the viability of a subset of companies and industries after government stimulus begins to run out. On the other hand, I believe government bonds and investment grade credit could perform well within moderately tight bands as monetary policy is likely to act as a cap on yields rising and spreads widening,” he continues.

More lockdowns?

If a second wave were to happen, Custard believes the negative economic impact of widespread lockdowns are likely to prove too damaging for them to be implemented again in a broad fashion. It also poses a wider question: would people actually observe the rules if a second round of restrictions came into force? As seen in the UK, more people were seen disobeying lockdown rules once the weather started getting warmer. Even in early July, despite the government advising against travelling unless essential, many Brits flocked overseas to Spain, Italy and Croatia.2

Instead of a second government-enforced lockdown, Custard believes there will likely be more selective disruption across countries, states, and sectors of the economy but he also believes central banks will come to the rescue if necessary. “One thing that’s likely to remain supportive is monetary policy,” he says. For Custard, the key to likelihood of a second wave is how quickly a vaccination can be created, and whether countries’ healthcare systems have the capacity to handle an influx of patients if need be. “One concern is the ability of medical systems to absorb any increase in hospitalizations and any resulting social distancing/precautionary measures that need to take place,” says Custard.

“Until there is a vaccine, companies are likely to have to navigate the impact on consumers (demand side) and suppliers in their supply chain (supply side) of various rolling lock-downs, which could both be a challenge. Clearly, the closer we are to a vaccine the more the markets will look through any surge,” he continues.

According to the BBC, 80 different medical groups are researching vaccines globally, with some already starting clinical trials.3 Despite how fast medical researchers are working, a successful vaccine could take years to develop. Some are hopeful a vaccine will be out by mid-2021.4

Road to recovery?

Economists and investors around the world are debating on which letter of recovery the economy will take with ‘V’, ‘U’, ‘W’ and ‘L’ being some of the top contenders, but Custard believes the focus on recovery masks some important issues.

“Online and digital companies will likely continue to prosper, however small and medium-sized enterprises (SMEs) will take more time as we are likely to see an initial wave of insolvencies after the government stimulus runs out. Some sectors of the economy are likely to remain impaired for an extended period, travel and tourism, for example, while others, such as online and delivery, will prosper,” he says.

In regards to GDP, Custard’s belief is that overall GDP with developed markets will not hit pre-Covid-19 GDP levels into late 2021 or 2022 but he is interested in seeing how countries around the world prepare for a second wave. “With the right precautions, if a second wave does happen, hopefully it won’t be as sociologically and economically damaging as the first,” he concludes.

1 www.bbc.com: ‘Coronavirus: What is a second wave and is one coming?’

2 BBC: Coronavirus: UK had to act 'rapidly and decisively' on Spain quarantine. July 27, 2020.

3 www.globalnews.cn: ‘Chinese COVID-19 vaccine approved to enter Phase III clinical trial in Brazil’, 8 July 2020

4 www.bbc.com: ‘Coronavirus vaccine: When will we have one?’, 2 July 2020

 

All investments involve some level of risk, including loss of principal. Certain investments have specific or unique risks. No investment strategy or risk management technique can guarantee returns or eliminate risk in any market environment.

Views expressed are those of the author stated and do not reflect views of other managers or the firm overall. Views are current as of the date of this publication and subject to change. This information contains projections or other forward-looking statements regarding future events, targets or expectations, and is only current as of the date indicated. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Forecasts, estimates and certain information contained herein are based upon proprietary research and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. Please consult a legal, tax or financial professional in order to determine whether an investment product or service is appropriate for a particular situation.

Newton and/or the Newton Investment Management’s brand refers to Newton Investment Management Limited. Newton is incorporated in the United Kingdom (Registered in England no. 1371973) and is authorized and regulated by the Financial Conduct Authority in the conduct of investment business. Newton is a subsidiary of The Bank of New York Mellon Corporation. Newton is registered with the SEC in the United States of America as an investment adviser under the Investment Advisers Act of 1940. Newton’s investment business is described in Form ADV, Part 1 and 2, which can be obtained from the SEC.gov website or obtained upon request.

BNY Mellon Investment Management is one of the world’s leading investment management organizations and one of the top U.S. wealth managers, encompassing BNY Mellon’s affiliated investment management firms, wealth management organization and global distribution companies. BNY Mellon is the corporate brand of The Bank of New York Mellon Corporation and may also be used as a generic term to reference the Corporation as a whole or its various subsidiaries generally.

No part of this material may be reproduced in any form, or referred to in any other publication, without express written permission. BNY Mellon Investment Adviser, Inc., Newton and BNY Mellon Securities Corporation are subsidiaries of BNY Mellon.

© 2020 BNY Mellon Securities Corporation, distributor, 240 Greenwich Street, 9th Floor, New York NY, 10286

MARK-136979-2020-08-21